What Researchers Did
This study reported on the successful use of a new antibiotic, Ciprofloxacin, in four cases of malignant external otitis (MEO) that had not responded to standard treatments.
What They Found
Researchers found that Ciprofloxacin successfully treated four patients with malignant external otitis (MEO) who had not improved with traditional therapies. This report was the first to document the use of Ciprofloxacin for MEO, highlighting its effectiveness against bacteria like Pseudomonas aeruginosa.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a case report involving only four patients, this study's findings cannot be broadly applied to all individuals with malignant external otitis.